enVVeno Medical Corp (NVNO) filed an 8-K on July 14, 2026, to disclose an investor presentation under Regulation FD. The presentation is attached as Exhibit 99.1 and is intended for use in meetings with investors and analysts. The filing states that the information is not considered 'filed' under the Securities Exchange Act.
View Full Filing (SEC EDGAR)Envveno Medical CORP
+$1.0M
Net Activity
Institutions Holding
17
Popularity Rank
#8590
Avg Weight
0.02%
Total Value
$1.0M
Ownership Trend
17 institutions currently hold NVNO, with 15 net buyers and 0 net sellers this quarter.
Institutional Moves
Institutional Moves (Q1 2026)
Significantly Increased
Based on recent trading activity
Net Selling Institutions
0
Net Buying Institutions
15
Key Holders
Key Holders
Top 5 by Value
Quarterly Activity
Recent Activity
+$932.8K
Total Buy Value
$0.0
Total Sell Value
15
Net Buyers
0
Net Sellers
Insider Trading (Form 4)
Form 144 Pre-Sale Notices
1
Filings (90d)
$1K
Total Est. Value
140 shares
Planned Shares
| Filer | Filing Date | Est. Value |
|---|---|---|
| Duhay Francis | 2026-06-11 | $1K |
Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。
Beneficial Ownership (13D/13G)
No Schedule 13D/13G filings for this ticker
Material Events (8-K)
FAQ
Who are the top institutional investors holding ENVVENO MEDICAL CORP (NVNO)?
What is the overall institutional sentiment toward NVNO recently?
Which institutions have been selling or reducing their NVNO positions?
Are there any notable investors adding NVNO to their portfolios?
Related Stocks
Trending Institutional Adds
The most-added stocks by 13F institutions this quarter
Microsoft CORP
Institutions Holding
6,150
Total reported value
$2.1T
3245 13F institutions increased their position this quarter
Amazon.com INC
Institutions Holding
5,957
Total reported value
$1.5T
3028 13F institutions increased their position this quarter
Nvidia CORP
Institutions Holding
5,764
Total reported value
$3.0T
2743 13F institutions increased their position this quarter